Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
PYC Therapeutics is a biotechnology business based in Australia. PYC Therapeutics shares (PYC) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. PYC Therapeutics has a trailing 12-month revenue of around $9.1 million. If you're looking to buy shares, check out the steps below.
How to buy shares in PYC Therapeutics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for PYC Therapeutics . Find the share by name or ticker symbol: PYC. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PYC Therapeutics reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of PYC Therapeutics . Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
Long-term investing
Our top pick for
Low-cost broker
PYC Therapeutics stock price (ASX:PYC)
Use our graph to track the performance of PYC stocks over time.PYC Therapeutics shares at a glance
Information last updated 2022-06-22.
| 52-week range | $0.061 - $0.165 |
|---|---|
| 50-day moving average | $0.0824 |
| 200-day moving average | $0.1169 |
| Target price | $0.02 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.005 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
1 - 9 of 9
Is it a good time to buy PYC Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
PYC Therapeutics price performance over time
Historical closes compared with the last close of A$0.073
| 1 month (2022-05-27) | 0.073 |
|---|---|
| 3 months (2022-03-28) | -26.26% |
| 6 months (2021-12-24) | -47.86% |
| 1 year (2021-06-28) | -51.33% |
|---|---|
| 2 years (2020-06-26) | -33.64% |
| 3 years (2019-06-28) | 156.14% |
PYC Therapeutics financials
| Revenue TTM | $9.1 million |
|---|---|
| Gross profit TTM | $3.1 million |
| Return on assets TTM | -18.92% |
| Return on equity TTM | -31.85% |
| Profit margin | -185.43% |
| Book value | 0.015 |
| Market capitalisation | $254.5 million |
TTM: trailing 12 months
PYC Therapeutics share dividends
We're not expecting PYC Therapeutics to pay a dividend over the next 12 months.
PYC Therapeutics share price volatility
Over the last 12 months, PYC Therapeutics 's shares have ranged in value from as little as $0.061 up to $0.165. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while PYC Therapeutics 's is 0.392. This would suggest that PYC Therapeutics 's shares are less volatile than average (for this exchange).
PYC Therapeutics overview
PYC Therapeutics Limited, a development-stage biotechnology company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and VP-002, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for retinal and central nervous system diseases. The company was formerly known as Phylogica Limited and changed its name to PYC Therapeutics Limited in November 2019. PYC Therapeutics Limited was incorporated in 2001 and is based in Nedlands, Australia.
PYC Therapeutics in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
How to invest in the Australia Sunny Glass Group IPO
Everything we know about the Australia Sunny Glass Group IPO, plus information on how to buy in.
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
Ask an Expert
